Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting β2-Agonists in Patients With COPD-Reference-Cited by-同舟云学术

Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting β2-Agonists in Patients With COPD

Published:2023-04 Issue:4 Volume:163 Page:799-814
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Weng Ching-Fu^ORCID,Wu Chien-Chih^ORCID,Wu Mei-Hsuan,Lin Fang-Ju^ORCID

Funder

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference36 articles.

1. Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study;Chapman;Chest,2011

2. The efficacy and safety of the novel long-acting β2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial;Hanania;Chest,2012

3. A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT trial);Tashkin;Rev Port Pneumol,2009

4. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial;Calverley;Lancet Respir Med,2018

5. Once-daily umeclidinium/vilanterol 125/25 mcg in COPD: a randomized, controlled study;Celli;Chest,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisión narrativa de la terapia inhalatoria en la EPOC;Medicina de Familia. SEMERGEN;2024-10

2. Lung regeneration: diverse cell types and the therapeutic potential;MedComm;2024-02

3. Real-world comparative effectiveness of three single-inhaler dual bronchodilators for the treatment of COPD;European Respiratory Journal;2023-06-21

4. Comparison Among Different Inhalers in COPD;Chest;2023-04